Kakamachi (Solanum nigrum): The Overlooked Hepatoprotective Herb

Dr. Meera Iyer — Fri, 12 Jun 2026 07:30:00 +0000

Kakamachi is an established Ayurvedic drug with a defined pharmacopoeial profile, while modern hepatoprotective evidence remains predominantly preclinical.

The Ayurvedic Pharmacopoeia of India identifies Kakamachi as the dried whole plant of Solanum nigrum Linn. Its profile is katu-tikta rasa, laghu, sara and snigdha guna, ushna virya, and katu vipaka. Its listed actions include bhedana, hridya, kaphahara, pittahara, rasayana, svaraya, vatahara and vrishya. Kakamachi is absent from Charaka’s ten-herb Jivaniya Mahakashaya.

Charaka Samhita Chikitsa Sthana Chapter 16 does not prescribe Kakamachi for Kamala; in the Yogaraja and Tapyadi regimens there, Kakamachi is among foods to be avoided after the medicine digests. Sushruta Samhita does include Kakamachi with other ingredients in a medicated ghee for Pandu-roga. This is a compound-formula record, not a single-herb liver prescription.

Phytochemical Profile: What’s Actually Inside

The official monograph conservatively records alkaloids and saponins. Modern reviews describe steroidal alkaloids, steroidal saponins, phenolic compounds, flavonoids and polysaccharides in different plant parts and extracts. Different preparations need not contain the same constituents or concentrations.

Alkaloids and glycoalkaloids: Verified constituents and an important reason that identity, plant part, maturity and dose matter.
Saponins: Recorded in both the pharmacopoeia and modern reviews, but their presence alone does not establish an anti-fibrotic treatment.
Phenolics and flavonoids: Found in studied leaves, fruits and extracts and associated with antioxidant activity in laboratory research.
Polysaccharides: Reported in reviews, although findings from an isolated fraction or berry extract cannot automatically be applied to the whole Ayurvedic drug.

Chemical identification does not establish a human indication, dose or long-term safety.

The Research Landscape: 2024-2026

Experimental Hepatotoxicity Models

A 2008 rat study reported protection against carbon-tetrachloride-induced oxidative liver injury. A 2016 study investigated alcoholic liver damage in primary hepatocytes and mice, and a 2025 rat study evaluated a methanolic leaf extract against carbon-tetrachloride injury. They do not prove treatment of medication-induced injury in people or justify converting animal doses into household doses.

Metabolic Fat Accumulation and NAFLD

A 2017 study examined Solanum nigrum polyphenol extracts in experimental models of hepatic fat accumulation. It was not a patient trial.

Established care for metabolic fatty liver disease centers on medical assessment, healthy food choices, portion control, physical activity and gradual weight loss when appropriate. NIDDK states that weight loss can reduce liver fat and, at greater levels, may reduce inflammation and fibrosis. Herbs should not displace diagnosis, monitoring or evidence-based care.

Anti-Fibrotic Research

A 2008 mouse study investigated Solanum nigrum extract in thioacetamide-induced liver fibrosis and reported an inhibitory effect in that model. It does not prove that solamargine reverses human fibrosis or that ordinary preparations prevent cirrhosis.

Classical Vs. Modern: A Comparative Analysis

Parameter	Verified Ayurvedic Record	Verified Modern Evidence	Interpretation
Classical profile	Katu-tikta rasa; laghu, sara and snigdha guna; ushna virya; katu vipaka	No direct biomedical equivalent	Use within Ayurvedic assessment, not as a laboratory mechanism
Rasayana	Listed as a pharmacopoeial karma	Antioxidant effects occur in experimental research	Not proof of longevity or telomere protection
Shotha and Jvara	Both are pharmacopoeial therapeutic uses	Reviews summarize experimental anti-inflammatory activity	Preclinical support, not a verified clinical protocol
Pandu context	Sushruta includes it in a multi-ingredient medicated ghee	Several extracts are hepatoprotective in animal models	Indirect overlap, not proof for hepatitis treatment
Human liver disease	Charaka Chapter 16 does not give the claimed Kamala prescription	Evidence is chiefly cellular or animal	Single-herb efficacy and therapeutic safety remain unestablished

Safety: The Glycoalkaloid Question

Kakamachi contains alkaloids, and steroidal glycoalkaloids in Solanum plants can be toxic at sufficient exposure. Concentrations vary with species, plant part, maturity, growing conditions and preparation.

A study of selected cultivated vegetable nightshade entries, including Solanum nigrum, found glycoalkaloid measurements compatible with food use in those tested samples. That cannot be generalized to all wild plants or extracts. The pharmacopoeia specifies an authenticated dried whole-plant drug, not casual foraging.

Critical safety caveats:

Never combine Kakamachi with honey. Charaka lists the combination as samyoga viruddha.
Use authenticated material only. Do not make medicine from an unidentified roadside or garden nightshade.
Pregnancy, breastfeeding and childhood require caution. Do not use medicinal Kakamachi in these groups without qualified supervision.
Review medicines and supplements. The FDA warns that supplements and medicines can interact.

Consult your Ayurvedic practitioner or healthcare provider before using Kakamachi, particularly if you have existing liver disease, are pregnant, or take pharmaceutical medications.

Practical Formulations and Dosage

The most defensible guidance comes from the official monograph rather than unverified extract protocols. It lists 5-10 mL in juice form. It is not permission to juice a wild plant without supervision.

Kakamachi juice: Pharmacopoeial dose, 5-10 mL; timing and frequency require an individualized prescription.
Hridayarnava Rasa: Listed as an important formulation containing Kakamachi.
Maha Vishagarbha Taila: Also listed; as a medicated oil, its route and purpose differ from oral juice.
Rasaraja Rasa: Another listed formulation that requires qualified supervision.
Sushruta’s Pandu preparation: A medicated ghee with Kakamachi and other herbs, illustrating compound use rather than interchangeable single-herb dosing.

Honey is classically incompatible.

Clinical Scenarios Where Kakamachi May Be Discussed

After Potentially Hepatotoxic Medication

Abnormal liver tests after chemotherapy, pain medicines, antifungals or other drugs require medical evaluation and monitoring. Animal studies do not justify independently starting Kakamachi. Discussion requires understanding the cause, severity and current treatment. For context, see our analysis of how Ayurvedic herbs interact with metabolic pathways.

Metabolic Fatty Liver Disease

Kakamachi cannot presently be presented as a clinically validated adjunct for NAFLD or MASLD. Priorities are diagnosis, metabolic-risk management, sustainable diet, physical activity and weight reduction when indicated. Any herb should be secondary and coordinated with the clinician monitoring tests and medicines.

Chronic Inflammatory Disease

Experimental anti-inflammatory activity does not prove benefit, especially amid complex medication regimens.

The Microbiome Connection

A 2024 study reported that a Solanum nigrum berry extract affected gut microbiota and liver-related outcomes in chronically ethanol-fed mice. It tested berry extract in mice, not polysaccharides in people with NAFLD. It is not clinical proof or a basis for prescribing the whole herb.

Changes in selected bacterial groups in an animal model do not automatically predict human benefit. For a broader Ayurvedic discussion, see our guide on gut mucosal barrier repair.

Why This Herb Is Still Overlooked

Kakamachi is not a proven therapy ignored by modern medicine. Studies use varied plant parts, extracts and models, usually cells or toxin-induced animal injury. These cannot be treated as one standardized clinical intervention.

The classical record also requires precision. The pharmacopoeia verifies a substantial Ayurvedic profile, but Charaka’s Jivaniya group does not include Kakamachi, Charaka Chikitsa Sthana 16 does not give the Kamala prescription, and Sushruta’s reference is a multi-ingredient Pandu formula.

The defensible conclusion is that classical use and experimental research provide a credible reason for further study. They do not prove that Kakamachi prevents fibrosis, reverses fatty liver, treats hepatitis or restores the liver after medication. Diagnosed liver disease needs qualified, coordinated care. People with cirrhosis should avoid alcohol and discuss every herbal supplement with their doctor.

All information in this article is for educational purposes. Kakamachi should be used only under the supervision of a qualified Ayurvedic practitioner or healthcare provider. Do not self-treat liver disease with herbal preparations without medical supervision.

Solanum nigrum – Ayurved Healing